KIF2C exerts an oncogenic role in nonsmall cell lung cancer and is negatively regulated by miR‐325‐3p

MicroRNAs associated with therapy of non-small cell lung cancer

(2018) Junmi Lu et al.   International Journal of Biological Sciences

Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer

(2017) Antoine Legras et al.   Cancers

GTSE1 tunes microtubule stability for chromosome alignment and segregation by inhibiting the microtubule depolymerase MCAK

(2016) Shweta Bendre et al.   JOURNAL OF CELL BIOLOGY

Current Status of Immunotherapy for Non-Small-Cell Lung Cancer

(2016) Martina Imbimbo et al.   TUMORI

KIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients

(2016) Hao Duan et al.   Oncotarget

Current Status of Immunotherapy for Non-Small-Cell Lung Cancer

(2016) Martina Imbimbo et al.   TUMORI JOURNAL

Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer

(2015) Shihua Yao et al.   BIOMEDICINE & PHARMACOTHERAPY

Spatiotemporal dynamics of Aurora B-PLK1-MCAK signaling axis orchestrates kinetochore bi-orientation and faithful chromosome segregation

(2015) Hengyi Shao et al.   Scientific Reports

Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance

(2014) Fung Zhao et al.   PLoS One

Aurora A orchestrates entosis by regulating a dynamic MCAK–TIP150 interaction

(2014) Peng Xia et al.   Journal of Molecular Cell Biology

MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells

(2013) W. Zhang et al.   Clinical & Translational Oncology

MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer

(2013) Bing Li et al.   LUNG CANCER

MiR-134/487b/655 Cluster Regulates TGF- -Induced Epithelial-Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells

(2013) K. Kitamura et al.   MOLECULAR CANCER THERAPEUTICS

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines

(2013) S Grosso et al.   Cell Death & Disease

Relation between the expression of mitotic centromere–associated kinesin and the progression of squamous cell carcinoma of the tongue

(2013) Cheng-Qin Wang et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

Increased expression of miR-325-3p by urocortin 2 and its involvement in stress-induced suppression of LH secretion in rat pituitary

(2012) Takahiro Nemoto et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Kinesin family member 2C (KIF2C/MCAK) is a novel marker for prognosis in human gliomas

(2011) Li Bie et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

The kinesin-13 MCAK has an unconventional ATPase cycle adapted for microtubule depolymerization

(2011) Claire T Friel et al.   EMBO JOURNAL

The Human Protein Atlas as a proteomic resource for biomarker discovery

(2011) F. Pontén et al.   JOURNAL OF INTERNAL MEDICINE

Overexpression of Mitotic Centromere-Associated Kinesin Stimulates Microtubule Detachment and Confers Resistance to Paclitaxel

(2011) A. Ganguly et al.   MOLECULAR CANCER THERAPEUTICS

Effects of anti-microtubule agents on microtubule organization in cells lacking the kinesin-13 MCAK

(2010) David G. Hedrick et al.   CELL CYCLE

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

(2009) Balazs Györffy et al.   BREAST CANCER RESEARCH AND TREATMENT

Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer

(2008) K Ishikawa et al.   BRITISH JOURNAL OF CANCER